Charles Darwin told us that it is not the strongest of the species that survives, nor the most intelligent, but the one most responsive to change. Biotech 2010—Life Sciences: Adapting for Success, Burrill & Company’s latest annual report on the industry, provides insight into biotech’s changing environment and how not to just survive but succeed.

Learn how to thrive Available in April 2010, the publication provides thoughtful information and analysis on how companies need to adapt to major challenges to their business development in order to be successful in 2010 and beyond. These include: raising capital, impending healthcare reform, comparative effectiveness research, generics, biosimilars, reimbursement pressures and regulatory changes. In addition Biotech 2010 presents:

• Comprehensive 2009 industry financials, private and public capital raised, M&A/Partnering activity of life sciences companies operating in the United States, Europe, Canada, and Asia.
• Analysis on key developments in healthcare, personalized medicine, biogreentech, emerging technologies, politics and policy and globalization…and much more.

Click here to view the Table of Contents.

This year we are inviting companies to purchase an electronic version of the book with a license that allows them to post it on their corporate intranet so the book can be made available to all employees at an affordable price. For the price of a few copies, you can now place Biotech 2010 in the hands of all your employees and provide them with the information, insight, and analysis that they will need to be successful going forward.

The pricing for a PDF version and license is tiered as follows. Just click on the appropriate tier below to order your PDF and license:

• Small Companies (up to 50 employees): $1,000
• Medium Companies (51-250 employees): $2,500
• Large Companies (250-10,000 employees): $5,000
• Big pharma/Top Tier (More than 10,000 employees): $10,000